WallStreetZenWallStreetZen

NYSE: OMI
Owens & Minor Inc Stock Forecast, Predictions & Price Target

Analyst price target for OMI

Based on 4 analysts offering 12 month price targets for Owens & Minor Inc.
Min Forecast
$23.00+37.72%
Avg Forecast
$25.25+51.2%
Max Forecast
$28.00+67.66%

Should I buy or sell OMI stock?

Based on 4 analysts offering ratings for Owens & Minor Inc.
Buy
Strong Buy
1 analysts 25%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OMI stock forecasts and price targets.

OMI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-06
lockedlocked$00.00+00.00%2024-04-30
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2024-01-29

1 of 1

Forecast return on equity

Is OMI forecast to generate an efficient return?
Company
21.37%
Industry
-38.56%
Market
82.5%
OMI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OMI forecast to generate an efficient return on assets?
Company
3.67%
Industry
6.72%
OMI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMI earnings per share forecast

What is OMI's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.53
Avg 2 year Forecast
$1.91
Avg 3 year Forecast
$2.20

OMI revenue forecast

What is OMI's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$10.7B+2.33%
Avg 2 year Forecast
$11.0B+5.75%
Avg 3 year Forecast
$11.4B+9.18%
OMI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OMI revenue growth forecast

How is OMI forecast to perform vs Medical Distribution companies and vs the US market?
Company
2.97%
Industry
6.81%
Market
9.95%
OMI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OMI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OMI vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
OMI$16.70$25.25+51.20%Buy
PDCO$22.63$30.00+32.57%Buy
ZYXI$8.99$18.00+100.22%Buy
EDAP$5.38$19.00+253.16%Buy
AHG$0.74N/AN/A

Owens & Minor Stock Forecast FAQ

Is Owens & Minor Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: OMI) stock is to Buy OMI stock.

Out of 4 analysts, 1 (25%) are recommending OMI as a Strong Buy, 0 (0%) are recommending OMI as a Buy, 3 (75%) are recommending OMI as a Hold, 0 (0%) are recommending OMI as a Sell, and 0 (0%) are recommending OMI as a Strong Sell.

If you're new to stock investing, here's how to buy Owens & Minor stock.

What is OMI's earnings growth forecast for 2024-2026?

(NYSE: OMI) Owens & Minor's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 25.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.82%.

Owens & Minor's earnings in 2024 is -$38,769,000.On average, 3 Wall Street analysts forecast OMI's earnings for 2024 to be $116,791,463, with the lowest OMI earnings forecast at $113,983,939, and the highest OMI earnings forecast at $118,573,896. On average, 3 Wall Street analysts forecast OMI's earnings for 2025 to be $146,113,640, with the lowest OMI earnings forecast at $138,463,711, and the highest OMI earnings forecast at $155,293,555.

In 2026, OMI is forecast to generate $167,915,937 in earnings, with the lowest earnings forecast at $162,943,483 and the highest earnings forecast at $172,888,391.

What is OMI's revenue growth forecast for 2024-2026?

(NYSE: OMI) Owens & Minor's forecast annual revenue growth rate of 2.97% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Owens & Minor's revenue in 2024 is $10,423,798,000.On average, 2 Wall Street analysts forecast OMI's revenue for 2024 to be $815,954,028,191, with the lowest OMI revenue forecast at $815,339,356,411, and the highest OMI revenue forecast at $816,568,699,970. On average, 2 Wall Street analysts forecast OMI's revenue for 2025 to be $843,259,301,553, with the lowest OMI revenue forecast at $836,626,813,283, and the highest OMI revenue forecast at $849,891,789,822.

In 2026, OMI is forecast to generate $870,623,861,863 in revenue, with the lowest revenue forecast at $863,295,995,066 and the highest revenue forecast at $877,951,728,661.

What is OMI's forecast return on assets (ROA) for 2024-2027?

(NYSE: OMI) forecast ROA is 3.67%, which is lower than the forecast US Medical Distribution industry average of 6.72%.

What is OMI's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OMI price target, the average OMI price target is $25.25, with the highest OMI stock price forecast at $28.00 and the lowest OMI stock price forecast at $23.00.

On average, Wall Street analysts predict that Owens & Minor's share price could reach $25.25 by May 6, 2025. The average Owens & Minor stock price prediction forecasts a potential upside of 51.2% from the current OMI share price of $16.70.

What is OMI's Earnings Per Share (EPS) forecast for 2024-2026?

(NYSE: OMI) Owens & Minor's current Earnings Per Share (EPS) is -$0.50. On average, analysts forecast that OMI's EPS will be $1.53 for 2024, with the lowest EPS forecast at $1.49, and the highest EPS forecast at $1.55. On average, analysts forecast that OMI's EPS will be $1.91 for 2025, with the lowest EPS forecast at $1.81, and the highest EPS forecast at $2.03. In 2026, OMI's EPS is forecast to hit $2.20 (min: $2.13, max: $2.26).

What is OMI's forecast return on equity (ROE) for 2024-2027?

(NYSE: OMI) forecast ROE is 21.37%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.